CardiaTec Biosciences
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
Signals
Website registeredApr 19, 2022 (4 years old)
Timeline
- Website created
- Date unknown
PPlug and Play · accelerator or program
Source: public.dxp.playbook.vc
Founders and team
RP
Raphael Peralta CEO & Co-founderLinkedIn · source: cardiatec.aiNH
Namshik Han CTO & Co-founderLinkedIn · source: cardiatec.aiTZ
Thelma Zablocki COO & Co-foundersource: cardiatec.ai
Investors
AAPEX Ventures
CContinuum Health Ventures
CCrista Galli Ventures
LLaidlaw Scholars Ventures
MMaximilien Levesque
MMontage Ventures
NNaheed Kurji
PPanacea Capital
UUniversity of Cambridge Enterprise
Companies like CardiaTec Biosciences
CCORE Biomedicine$21M Series A · Jul 2026
EElement Biosciences$175M Series B+ · Jun 2026
CC12.ai$7M Seed · Mar 2026
DDigital Ether ComputingSeed · Jul 2026
YYSBiotikSeed · Mar 2026
IInductive Bio$25M Series A · May 2025
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/cardiatec-biosciences (get a free API key).